RankAlpha logo
Back to Rankings

MBRX

Moleculin BiotechF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MBRX vs peer average
32/100
MBRX vs. peer average (F vs. D)
Grade spread
C 2 · D 5 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

VTGN is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $11.54M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerVTGNVistagen Therapeutics
MBRX
Moleculin Biotech
VTGN
Vistagen Therapeutics
Grade
F
D
Momentum
67
7
Value
41
58
Sentiment
29
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs VTGN

MBRX / VTGN
Grade Position
Below peers
MBRX vs. peer average (F vs. D)
32/100
Momentum
67
MBRX
Value
41
VTGN
Sentiment
29
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MBRX
1
VTGN
Vistagen Therapeutics Inc Common
D
40/100
-1
2
KPRX
Kiora Pharmaceuticals Inc Common
D
40/100
-1
3
PHIO
Phio Pharmaceuticals Corp Common
C
60/100
-2
4
PDSB
PDS Biotechnology Corp Common
D
40/100
-1
5
BLRX
BioLineRX Ltd ADR
F
20/100
Even
VTGN is the first peer returned for this comparison set.